|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.42 USD | +7.79% |
|
+11.22% | +17.94% |
| 07-28 | UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating | MT |
| 07-13 | Enovis Corporation Launches Ct-Revitl Laser Therapy System for Veterinary Care | CI |
Company Valuation: Enovis Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,115 | 2,898 | 3,058 | 2,452 | 1,524 | 1,809 | - | - |
| Change | - | -59.27% | 5.53% | -19.83% | -37.86% | 18.71% | - | - |
| Enterprise Value (EV) 1 | 8,483 | 2,898 | 3,293 | 3,733 | 2,784 | 3,016 | 2,877 | 2,703 |
| Change | - | -65.84% | 13.64% | 13.35% | -25.43% | 8.32% | -4.6% | -6.04% |
| P/E | 99.9x | -214x | -91.8x | -2.94x | -1.28x | 262x | 32.6x | 50.3x |
| PBR | 1.56x | - | 0.89x | 0.96x | 1.02x | 1.16x | 1.09x | 1.02x |
| PEG | - | 2x | -1x | -0x | -0x | -3x | 0x | -1.4x |
| Capitalization / Revenue | 1.85x | 1.85x | 1.79x | 1.16x | 0.68x | 0.77x | 0.73x | 0.7x |
| EV / Revenue | 2.2x | 1.85x | 1.93x | 1.77x | 1.24x | 1.29x | 1.17x | 1.05x |
| EV / EBITDA | 13.6x | 12.3x | 12.2x | 9.92x | 6.91x | 7.01x | 6.07x | 5.17x |
| EV / EBIT | 23.6x | 18.2x | 17.7x | 14.4x | 9.86x | 9.84x | 8.35x | 7.21x |
| EV / FCF | 33.7x | -18x | 258x | -55.5x | 140x | 46x | 18.1x | 15.2x |
| FCF Yield | 2.97% | -5.57% | 0.39% | -1.8% | 0.72% | 2.17% | 5.53% | 6.58% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.38 | -0.25 | -0.61 | -14.93 | -20.75 | 0.12 | 0.9633 | 0.625 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,854 | 1,563 | 1,707 | 2,108 | 2,248 | 2,345 | 2,466 | 2,581 |
| EBITDA 1 | 623.1 | 236.1 | 269.2 | 376.5 | 403 | 430.2 | 473.7 | 522.9 |
| EBIT 1 | 360.1 | 159.4 | 185.6 | 259.2 | 282.3 | 306.4 | 344.6 | 374.8 |
| Net income 1 | 71.66 | -13.29 | -33.26 | -825.5 | -1,184 | 2.98 | 54.14 | 36.5 |
| Net Debt 1 | 1,368 | - | 235 | 1,281 | 1,260 | 1,207 | 1,068 | 894.6 |
| Reference price 2 | 137.91 | 53.52 | 56.02 | 43.88 | 26.64 | 31.42 | 31.42 | 31.42 |
| Nbr of stocks (in thousands) | 51,594 | 54,150 | 54,594 | 55,875 | 57,189 | 57,563 | - | - |
| Announcement Date | 2/22/22 | 2/23/23 | 2/22/24 | 2/26/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 261.83x | 1.29x | 7.01x | -.--% | 1.81B | |
| 26.51x | 5.12x | 17.57x | 1.06% | 131B | |
| 19.92x | 2.5x | 9.63x | 2.57% | 13.52B | |
| -211.24x | 14.33x | 1701.18x | -.--% | 10.07B | |
| 23.85x | 11.16x | 18.73x | 1.82% | 4.73B | |
| 25.57x | - | - | - | 2.58B | |
| 18.04x | 4.9x | 9.57x | 3.39% | 1.68B | |
| 135.24x | 1.34x | 6.64x | -.--% | 1.5B | |
| Average | 37.47x | 5.81x | 252.90x | 1.26% | 20.85B | |
| Weighted average by Cap. | 14.97x | 5.57x | 119.95x | 1.15% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ENOV Stock
- Valuation Enovis Corporation
Select your edition
All financial news and data tailored to specific country editions
